Xenotransplantation in China: Past, Present, and Future
Xenotransplantation · 2025
DOI: 10.1111/xen.70038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Xenotransplantation, 2025. Verfasst von Kai Xing und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medi…. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Heterografts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Frontier Biotechnology Key Project of National Key R & D Program of the Ministry of Science and Technology of China, Special Project of the Ministry of Science and Technology of China Supported by the State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Aca….
Abstract (Originalsprache)
Organ failure poses a substantial global health challenge, and xenotransplantation emerges as one of the most promising avenues to mitigate the critical shortage of donor organs. In recent years, numerous research institutions have undertaken clinical and preclinical xenotransplantation in humans, instilling hope for notable progress. Nevertheless, formidable obstacles persist before success can be fully achieved. Chinese researchers have been at the forefront of xenotransplantation studies, actively contributing to several pivotal areas: the identification of critical genes essential for xenotransplantation and the creation of genetically modified pigs; preclinical studies on pig‐to‐nonhuman primate organ and tissue xenotransplantation, as well as the utilization of genetically engineered pig‐derived biomaterials; contributions to both preclinical and clinical xenotransplantation research; and the formulation and refinement of xenotransplantation policies and ethical guidelines in China. In conclusion, this review seeks to not only acknowledge the contributions of Chinese researchers but also to encourage further collaboration between Chinese scholars and their international counterparts in advancing the field of xenotransplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Beijing Key Laboratory of Preclinical Research and Evaluation for Cardiovascular Implant Materials, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medic…
- Department of Cardiac Surgery, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Shenzhen Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, China.
Förderung
- Frontier Biotechnology Key Project of National Key R & D Program of the Ministry of Science and Technology of China
- Special Project of the Ministry of Science and Technology of China Supported by the State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Aca…
Zitieren
APA
Xing, K., Chang, Y., Zhang, X., Du, X., & Song, J. (2025). Xenotransplantation in China: Past, Present, and Future. Xenotransplantation. https://doi.org/10.1111/xen.70038
Vancouver
Xing K, Chang Y, Zhang X, Du X, Song J. Xenotransplantation in China: Past, Present, and Future. Xenotransplantation. 2025. doi:10.1111/xen.70038
BibTeX
@article{Xing2025,
author = {Xing, Kai and Chang, Yuan and Zhang, Xiulin and Du, Xingchao and Song, Jiangping},
title = {Xenotransplantation in China: Past, Present, and Future},
journal = {Xenotransplantation},
year = {2025},
doi = {10.1111/xen.70038}
}
EUVIMED